Dasatinib derivative 1

Dasatinib derivative 1 (2e) effectively releases nitric oxide (NO) and increases the concentration of 3’,5’-cyclic guanosine monophosphate (cGMP), while maintaining senescent cell-clearing activity. This compound can be utilized for research into chronic ocular hypertension (COHT) glaucoma.

O=C(CCC(OCCN1CCN(CC1)C2=CC(NC3=NC=C(C(NC4=C(C)C=CC=C4Cl)=O)S3)=NC(C)=N2)=O)OCCOCCOC5=NON(=O)=C5S(=O)(C6=CC=CC=C6)=O.O=S(O)(C)=O.O=S(O)(C)=O.O=S(O)(C)=O